2017 Kyoto Prize Symposium & BIOCOM
Hundreds of clinical trials involving immunotherapy, alone or combined with other treatments, are underway for nearly every type of cancer.
Please join us for the rare opportunity to salute Kyoto Prize laureate Tasuku Honjo with a panel of seasoned leaders in the Life Sciences industry, discussing immunology, therapeutic, medical, and legal issues and the challenges in moving to market.
The panel is moderated by Biocom’s president and CEO Joe Panetta. Biocom is California’s largest and most-experienced leader and advocate for the Life Sciences industry working on behalf of more than 800 members with offices located in San Diego, Los Angeles, Tokyo, and Washington, D.C. The featured panelists are: